Pharmaceutical stability testing to support global markets
Saved in:
Corporate Authors: | ; |
---|---|
Group Author: | |
Published: |
Springer,
|
Publisher Address: | New York |
Publication Dates: | c2010. |
Literature type: | Book |
Language: | English |
Series: |
Biotechnology: pharmaceutical aspects ; v. 12 |
Subjects: | |
Carrier Form: | xix, 265 p.: ill. ; 27 cm. |
ISBN: |
9781441908889 (hardback : alk. paper) 9781441908896 (e-book) 1441908897 (e-book) 1441908889 (hardback : alk. paper) |
Index Number: | R969 |
CLC: | R969.4-532 |
Call Number: | R969.4-532/A112/2007 |
Contents: |
Includes bibliographical references and index. Sect. IV. Stability data and operational practices. 23. Optimizing stability data package to facilitate NDA/MAA approval / Frank Diana -- 24. Maximize data for post approval changes / Paula J. Youngberg Webb -- 25. use of statistics to establish a stability trend: matrixing / earl Nordbrock -- 26. Setting specifications for drug substances / Jon V. Beaman -- 27. Setting specifications for drug products / Abbie Gentry -- 28. Highlights of investigating out-of-specifications test results / Saji thomas and Kim Huynh-Ba |